SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Asherson RA, Cervera R, Piette JC, Shoenfeld Y. The antiphospholipid syndrome: history, definition, classification, and differential diagnosis. In: AshersonRA, CerveraR, PietteJC, ShoenfeldY, editors. The antiphospholipid syndrome. Boca Raton (FL): CRC Press; 1996. pp. 312.
  • 2
    Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 36674.
  • 3
    Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998; 77: 195207.
  • 4
    Alarcón-Segovia D, Delezé M, Oria CV, Sánchez-Guerrero J, Gómez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 35365.
  • 5
    Cervera R, Font J, López-Soto A, Casals F, Pallarés L, Bové A, et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990; 49: 10913.
  • 6
    Mackworth-Young C, Loizou S, Walport M. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989; 48: 3627.
  • 7
    Font J, López-Soto A, Cervera R, Balasch J, Pallarés L, Navarro M, et al. The ‘primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991; 9: 6975.
  • 8
    Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, López-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 131 patients. Am J Med 1994; 96: 39.
  • 9
    Sammaritano LR. Pediatric and familial antiphospholipid syndromes. In: AshersonRA, CerveraR, PietteJC, ShoenfeldY, editors. The antiphospholipid syndrome. Boca Raton (FL): CRC Press; 1996. pp. 25966.
  • 10
    Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette J-C, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 130911.
  • 11
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 12
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 13
    Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 3447.
  • 14
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 58190.
  • 15
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al, European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 3407.
  • 16
    Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990; 33: 10651144.
  • 17
    AshersonRA, CerveraR, PietteJC, ShoenfeldY, editors. The antiphospholipid syndrome. Boca Raton (FL): CRC Press; 1996.
  • 18
    Ad Hoc Committee on Classification of Headaches. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 suppl 7: 196.
  • 19
    Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 21522.
  • 20
    Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 118590.
  • 21
    Harris EN, Pierangeli SS. “Equivocal” antiphospholipid syndrome. J Autoimmun 2000; 15: 815.
  • 22
    Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000; 43: 4403.
  • 23
    Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 9937.
  • 24
    Muñoz-Rodríguez FJ, Font J, Cervera R, Reverter JC, Tàssies D, Espinosa G, et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 1999; 29: 18290.
  • 25
    Balasch J, Carmona F, López-Soto A, Font J, Creus M, Fàbregues F, et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1993; 8: 22349.
  • 26
    Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 61420.
  • 27
    Derksen RHWM, de Groot PG, Nieuwenhuis HK, Christiaens GCML. How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis 2001; 60: 13.
  • 28
    Rai R, Cohen H, Dave M, Regan L. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314: 2537.
  • 29
    Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 21536.
  • 30
    Asherson RA, Piette JC, Cervera R. “Primary,” “secondary,” “catastrophic,” and other variants of the antiphospholipid syndrome. In: AshersonRA, CerveraR, PietteJC, ShoenfeldY, editors. The antiphospholipid syndrome. Boca Raton (FL): CRC Press; 1996. pp. 24958.
  • 31
    Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 1993; 72: 11324.
  • 32
    Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 50812.
  • 33
    Francès C, Piette JC, Saada V, Papo T, Wechsler B, Chosidow O, et al. Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature. Lupus 1994; 3: 1238.
  • 34
    Cervera R, Khamashta MA, Font J, Reyes PA, Vianna JL, López-Soto A, et al. High prevalence of significant heart valve lesions in patients with the “ primary” antiphospholipid syndrome. Lupus 1991; 1: 437.
  • 35
    Nochy D, Daugas E, Huong DL, Piette JC, Hill G. Kidney involvement in the antiphospholipid syndrome. J Autoimmun 2000; 15: 12732.